The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Imagine moving a computer mouse with only your thoughts. You think it, and it's done. It may be science fiction, but it's ...

Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Elon Musk's brain chip firm Neuralink has said that the US Food and Drug Administration (FDA) has approved its first human clinical trial, a critical milestone after earlier struggles to gain ...

Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...

Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

Disruptedcategory Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant September 18, 2024 Healthcare & Pharmaceuticalscategory Musk's Neuralink says second trial implant ...

Elon Musk’s backing of Donald Trump’s decisive victory for a second presidency gives the billionaire entrepreneur ...